DUBLIN, August 2, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/c2hchg/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018" report to their offering.
Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With a rise in the aging population globally, coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m), that has many useful properties of gamma-emitting tracer nuclide.
Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases.
This may be given to the patient in a number of ways, for e.g. they may be given through the mouth, through injections or placed into the eye or into the bladder. It is a small treatment, which includes use of simple substances containing radioactive isotopes. While treating cancer, these radioactive agents are taken up in the cancerous area to destroy the affected tissues. It works effectively by targeting the areas in the body where the cancer is present. Individuals are advised to intake radiopharmaceuticals only under the direct supervision of a doctor.
This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Radiopharmaceuticals Market Overview
Chapter 4 Market Definition & Supply Chain Analysis
Chapter 5 Global Radiopharmaceutical Generators Market
Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
Chapter 7 Global Radiopharmaceuticals Market, By Applications
Chapter 8 Global Radiopharmaceuticals Market, By Geography
Chapter 9 Market Share Analysis By Key Players
Chapter 10 Recommendations
Chapter 11 Company Profiles
- Cardinal Health Inc.
- Covidien Plc
- GE Healthcare
- IBA Group
- Lantheus Medical Imaging
- Monrol Nuclear Products, Inc.
- Nordion, Inc.
- NTP Radioisotopes (Pty) Ltd
- Positron Corporation
- Siemens Healthcare
For more information visit http://www.researchandmarkets.com/research/c2hchg/radiopharmaceutica
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved